$ProQR Therapeutics(PRQR.US)$ NEWS ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical data for its AX-0810 pipelin...
ProQR Therapeutics' short term liquidity and more cash than debt suggest it can manage its debt safely. Its 38% revenue growth is a positive sign, indicating potential for further strong growth.
Pharma industry has been doing well despite the recession, and I believe these companies will continue to do well moving forward (they have upcoming catalysts in q1/h1 2023) 1.$Viking Therapeutics(VKTX.US)$closest competitor to$Madrigal Pharmaceuticals(MDGL.US)$, which recently announced breakthroughs in the NASH space and price went up ×4 times. multiple catalysts in 2023 q1. 2.$ProQR Therapeutics(PRQR.US)$announced collaboration with LLY, their RNAI editing softwa...
$ProQR Therapeutics(PRQR.US)$Yesterday we didn't break the $3 resistance! I believe today we will! Price target up from $2 to $5! Shifted from Neutral to Overweight!💪🏻
$ProQR Therapeutics(PRQR.US)$easy. easy. Good news worth 3.75B✅ $2+ lesser commission if you compare to those few cents stock ✅ Good news in a NO NEWS market ✅ if this don't go pass $5 then nth much I can say about it
ProQR Therapeutics股票讨论区
NEWS
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical data for its AX-0810 pipelin...
ProQR Therapeutics Highlights New Platform Data From Presentation On Axiomer RNA Editing Technology, Company Says Platform Demonstrates Robust In Vivo Editing Capabilities Reporting Up To 70% Editing
Long Term Pharma Holds
1. $Viking Therapeutics(VKTX.US)$ closest competitor to $Madrigal Pharmaceuticals(MDGL.US)$ , which recently announced breakthroughs in the NASH space and price went up ×4 times. multiple catalysts in 2023 q1.
2. $ProQR Therapeutics(PRQR.US)$ announced collaboration with LLY, their RNAI editing softwa...
AH + 12/23 watchlist
$AMC院线(AMC.US)$$AppTech Payments(APCX.US)$$Core Scientific(CORZ.US)$$iMedia Brands(IMBI.US)$$车美仕(KMX.US)$$Mersana Therapeutics(MRSN.US)$$英伟达(NVDA.US)$$Oric Pharmaceuticals(ORIC.US)$$ProQR Therapeutics(PRQR.US)$$Rocket Pharmaceuticals(RCKT.US)$$Roku Inc(ROKU.US)$$Cassava Sciences(SAVA.US)$$特斯拉(TSLA.US)$$Expion360(XPON.US)$
22/12: Let's go!!
暂无评论